Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Alpha Terpineol: A Potential Anticancer Agent which Acts through Suppressing NF-κB Signalling

SAADIA BASHIR HASSAN, HALA GALI-MUHTASIB, HANNA GÖRANSSON and ROLF LARSSON
Anticancer Research June 2010, 30 (6) 1911-1919;
SAADIA BASHIR HASSAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sadia.hassan@medsci.uu.se
HALA GALI-MUHTASIB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANNA GÖRANSSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROLF LARSSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 30 no. 6 1911-1919
PubMed 
20651334

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 25, 2010
  • Revision received May 4, 2010
  • Accepted May 10, 2010
  • Published online July 22, 2010.

Copyright & Usage 
Copyright© 2010 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. SAADIA BASHIR HASSAN1,
  2. HALA GALI-MUHTASIB2,
  3. HANNA GÖRANSSON1 and
  4. ROLF LARSSON1
  1. 1Division of Clinical Pharmacology, Department of Medical Sciences, University Hospital, SE-751 85 Uppsala, Sweden
  2. 2Department of Biology, American University of Beirut, Lebanon
  1. Correspondence to: Saadia Bashir Hassan, Division of Clinical Pharmacology, Department of Medical Sciences, University Hospital, 751 85 Uppsala, Sweden. Tel: +46 186119381, Fax: +46 18519237, e-mail: sadia.hassan{at}medsci.uu.se
View Full Text

Statistics from Altmetric.com

Cited By...

  • 136 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 30 (6)
Anticancer Research
Vol. 30, Issue 6
June 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Alpha Terpineol: A Potential Anticancer Agent which Acts through Suppressing NF-κB Signalling
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Alpha Terpineol: A Potential Anticancer Agent which Acts through Suppressing NF-κB Signalling
SAADIA BASHIR HASSAN, HALA GALI-MUHTASIB, HANNA GÖRANSSON, ROLF LARSSON
Anticancer Research Jun 2010, 30 (6) 1911-1919;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Alpha Terpineol: A Potential Anticancer Agent which Acts through Suppressing NF-κB Signalling
SAADIA BASHIR HASSAN, HALA GALI-MUHTASIB, HANNA GÖRANSSON, ROLF LARSSON
Anticancer Research Jun 2010, 30 (6) 1911-1919;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Cytotoxic and Metalloproteinase-inhibitory Effects of Ellagic Acid Against Oral Squamous Cell Carcinoma
  • Artogomezianone Inhibits EGFR and Promotes Apoptosis in Non-small Cell Lung Cancer Cells
  • Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire